Source: International Congress 2015 – Pulmonary hypertension: management
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Donato Lacedonia (Molfetta, Italy), Donato Lacedonia, Michele Correale, Giovanna Elisiana Carpagnano, Giuseppe Antonio Palmiotti, Maria M. Lo Storto, Piergiuseppe Bonfitto, Matteo Di Biase, Maria Pia Foschino Barbaro. Lack correlation between FVC/DLC index and pulmonary hypertension in non sclerodermic patients. Eur Respir J 2015; 46: Suppl. 59, 3783

Member's Comments

No comment yet.

Related content which might interest you: Hemodynamic assessment of patients with pulmonary hypertension due to lung disease and/or hypoxia Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Hemodynamic and clinical relevance of “borderline pulmonary hypertension“ Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Age is independently associated with pulmonary arterial compliance in health and in patients with pulmonary vascular disease Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016 Effect of pulmonary-specific vasodilator therapy in patients with chronic obstructive pulmonary disease and pulmonary hypertension. A retrospective analysis Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 The evolution of effort tolerance and body composition in patients with idiopathic pulmonary arterial hypertension Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Simple, non-invasive methods to assess severity of pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Unique characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease compared to the rest of pulmonary arterial hypertension subgroups Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Stress-Doppler-Echocardiography for early detection of systemic sclerosis associated pulmonary arterial hypertension Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases Year: 2014 Pulmonary hypertension correction in patients with chronic obstructive pulmonary disease and essential hypertension Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Macitentan for pulmonary arterial hypertension (PAH): Early clinical experience of 94 patients Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Pulmonary arterial hypertension patients underrepresented in clinical trials – Are they different? Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Baseline hemodynamic predictors of treatment response in pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Pulmonary hypertension and COPD: Clinical assessment and biomarkers Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Specific pulmonary arterial hypertension therapy in COPD patients with severe pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Relationship between comorbidities and quality of life perceived by patients diagnosed with pulmonary hypertension: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension Year: 2019 Myocardial perfusion in patients with pulmonary hypertension of different etiology Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 Comparison of exercise capacity and exercise haemodynamic relationships between severe group 3 pulmonary hypertension and pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016 Limited and heterogeneous arterial narrowing in idiopathic pulmonary hypertension: Rethinking resistance Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 About cardiac output assessment in pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 PAH-specific therapies improve survival in patients with pulmonary arterial hypertension associated with connective tissue diseases: A Russian single centre experience Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014